Shandong Buchang Pharmaceuticals Co., Ltd. (603858)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
15. 87
-0.08
-0.5016%
¥
16.46B Market Cap
- P/E Ratio
0.5% Div Yield
7.65M Volume
- Eps
¥ 15.95
Previous Close Want to track 603858 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
603858 trading today lower at ¥15.87, a decrease of -0.5016% from yesterday's close, completing a monthly increase of 8.7731% or ¥1.28. Over the past 12 months, 603858 stock gained 1.4058%.
603858 pays dividends to its shareholders, with the most recent payment made on Aug 06, 2026. The next estimated payment will be in In 11 months on Aug 06, 2027 for a total of ¥0.18.
The last earnings report, released on Apr 25, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shandong Buchang Pharmaceuticals Co., Ltd. has completed 2 stock splits, with the recent split occurring on Aug 19, 2019.
The company's stock is traded on one exchange.
603858 Chart
People also search for
Shandong Buchang Pharmaceuticals Co., Ltd. (603858) FAQ
What is the stock price today?
The current price is ¥15.87.
On which exchange is it traded?
Shandong Buchang Pharmaceuticals Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 603858.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.5%.
What is its market cap?
As of today, the market cap is 16.46B.
Has Shandong Buchang Pharmaceuticals Co., Ltd. ever had a stock split?
Shandong Buchang Pharmaceuticals Co., Ltd. had 2 splits and the recent split was on Aug 19, 2019.
Shandong Buchang Pharmaceuticals Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chao Zhao CEO | SSE Exchange | CNE100002FV6 ISIN |
| CN Country | 8,311 Employees | 6 Aug 2026 Last Dividend | 17 Aug 2018 Last Split | - IPO Date |
Overview
Shandong Buchang Pharmaceuticals Co., Ltd. is a prominent entity in the Chinese pharmaceutical sector, specializing in the research and development, manufacturing, and distribution of medicinal products. Founded in 1993, the company has established a significant presence in Heze, China, focusing on addressing a wide array of health conditions through innovative health solutions. Its commitment to improving patient care has positioned it as a key player in the pharmaceutical industry, primarily targeting diseases that span across various medical fields.
Products and Services
The company's portfolio is diversified across multiple therapeutic areas, each aimed at improving health outcomes for patients suffering from specific conditions:
- Cardiac and Cerebral Vascular: Shandong Buchang Pharmaceuticals offers a range of medicines dedicated to treating conditions related to the heart and blood vessels, addressing ailments such as hypertension, coronary artery disease, and stroke. Their products in this category aim to enhance cardiovascular health and reduce the risk associated with vascular disorders.
- Urinary and Digestive: This category includes medicines designed to assist with the treatment of urinary tract infections, gastrointestinal disorders, and liver diseases. The company focuses on providing solutions that improve the function of the digestive and urinary systems.
- Respiratory: Shandong Buchang Pharmaceuticals develops products for the management and treatment of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and acute bronchitis. Their offerings in this area aim to relieve symptoms, improve lung function, and enhance the quality of life for patients with respiratory issues.
- Gynecological: The company also offers medicines tailored for women's health, specifically addressing conditions affecting the female reproductive system. These products are designed to treat a variety of gynecological issues, ensuring comprehensive care for female patients.
- Diabetes: Recognizing the growing prevalence of diabetes, Shandong Buchang Pharmaceuticals provides medications that help manage blood sugar levels, thereby contributing to the overall treatment and management of diabetes. Their focus in this area underscores the importance of offering effective options for patients coping with this chronic condition.
Contact Information
Address: No. 369 Zhonghua West Road, Heze, China, 274000
Phone: 86 40 0678 9828
Website: https://www.buchang.com
